AI Bias Analysis
4 models · Takes ~15 seconds
The arbitration process has protected patients but generated financial windfalls for some clinicians.
Source
Stat News
Opens original article in a new tab
The Trump administration disregards infectious disease playbook, CEPI offers vaccine funding, and other health news from Morning Rounds
The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion upfront.
Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing how much this will cost taxpayers.
A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using peptides.
